Receptors, Vasoactive Intestinal Peptide, Type II
"Receptors, Vasoactive Intestinal Peptide, Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pituitary adenylate cyclase-activating peptide receptor subtype found in LYMPHOCYTES. It binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE and regulates immune responses.
| Descriptor ID |
D051239
|
| MeSH Number(s) |
D12.776.543.750.695.665.750 D12.776.543.750.695.900.500
|
| Concept/Terms |
Receptors, Vasoactive Intestinal Peptide, Type II- Receptors, Vasoactive Intestinal Peptide, Type II
- VIP2 Receptors
- Receptors, VIP2
- VPAC2 Receptor
- Receptor, VPAC2
- Vasoactive Intestinal Peptide 2 Receptor
- PACAP Type III Receptor
- PACAPR-3 Protein
- PACAPR 3 Protein
- Vasoactive Intestinal Peptide Receptor 2
- Pituitary Adenylate Cyclase-Activating Peptide Receptor Type III
- Pituitary Adenylate Cyclase Activating Peptide Receptor Type III
- PACAP Receptors, Type III
- VIP Receptors, Type II
- Vasoactive Intestinal Peptide Receptors, Type II
- Receptors, Pituitary Adenylate Cyclase-Activating Peptide, Type III
- VIP2 Receptor
- Receptor, VIP2
- VIPR2 Protein
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Vasoactive Intestinal Peptide, Type II".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide [D12.776.543.750.695.665]
- Receptors, Vasoactive Intestinal Peptide, Type II [D12.776.543.750.695.665.750]
- Receptors, Vasoactive Intestinal Peptide [D12.776.543.750.695.900]
- Receptors, Vasoactive Intestinal Peptide, Type II [D12.776.543.750.695.900.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Vasoactive Intestinal Peptide, Type II".
This graph shows the total number of publications written about "Receptors, Vasoactive Intestinal Peptide, Type II" by people in this website by year, and whether "Receptors, Vasoactive Intestinal Peptide, Type II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Vasoactive Intestinal Peptide, Type II" by people in Profiles.
-
Kumar P, Tripathi SK, Chen CP, Wickstrom E, Thakur ML. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics. Mol Imaging Biol. 2019 02; 21(1):130-139.
-
Trabulsi EJ, Tripathi SK, Gomella L, Solomides C, Wickstrom E, Thakur ML. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study. BJU Int. 2017 06; 119(6):885-895.
-
Hao H, Zak DE, Sauter T, Schwaber J, Ogunnaike BA. Modeling the VPAC2-activated cAMP/PKA signaling pathway: from receptor to circadian clock gene induction. Biophys J. 2006 Mar 01; 90(5):1560-71.